Elevated STAT2 expression has been associated with poor prognosis in several cancers [18,19,20], and experimental evidence indicates that STAT2 can support tumor cell survival and chemoresistance through both canonical and non-canonical signaling mechanisms [21,22,23,24]. This evidence concerns the gene STAT2 and cancer.